Skip to search formSkip to main contentSkip to account menu

flutiform

Known as: fluticasone-formoterol 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AndrostadienesDrug CombinationsEthanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Patients’ ability to use a novel fluticasone propionate/formoterol breath-triggered inhaler (BTI) vs. budesonide/formoterol dry powder inhaler (DPI)
Introduction: GINA guidelines recognise the importance of correct inhaler technique and patient preference when individualising… 
2016
2016
Efficacy of switching to Flutiform in patients insufficiently controlled with Adoair, a conventional therapy : Pooled analysis of 4 studies
2016
2016
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Introduction: This study (ENCePP/SDPP/3702) assessed the long-term safety and efficacy of fluticasone propionate/formoterol… 
2013
2013
Flutiform, a new steroid/long‐acting beta‐agonist inhaler
Flutiform is a new inhaled steroid/long‐acting beta‐agonist combination containing fluticasone and formoterol. Here, the authors… 
2009
2009
Sicherheit von FlutiForm in der Langzeittherapie
2008
2008
Investor malaise stalks UK, European biotech